DICE Therapeutics Inc. (DICE)
DICE Therapeutics Statistics
Share Statistics
DICE Therapeutics has 47.76M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 47.76M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 50K |
| FTD / Avg. Volume | 2.85% |
Short Selling Information
The latest short interest is 4.36M, so 9.13% of the outstanding shares have been sold short.
| Short Interest | 4.36M |
| Short % of Shares Out | 9.13% |
| Short % of Float | 14.6% |
| Short Ratio (days to cover) | 5.2 |
Valuation Ratios
The PE ratio is -15.05 and the forward PE ratio is null. DICE Therapeutics's PEG ratio is 0.32.
| PE Ratio | -15.05 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | -6.55 |
| P/FCF Ratio | -18.47 |
| PEG Ratio | 0.32 |
Enterprise Valuation
DICE Therapeutics has an Enterprise Value (EV) of 781.19M.
| EV / Sales | 0 |
| EV / EBITDA | -9.41 |
| EV / EBIT | -12.14 |
| EV / FCF | -11.74 |
Financial Position
The company has a current ratio of 38.14, with a Debt / Equity ratio of -0.07.
| Current Ratio | 38.14 |
| Quick Ratio | 38.14 |
| Debt / Equity | -0.07 |
| Debt / EBITDA | -0.16 |
| Debt / FCF | -0.2 |
| Interest Coverage | -129.93 |
Financial Efficiency
Return on Equity is 43.53% and Return on Invested Capital is 49.26%.
| Return on Equity | 43.53% |
| Return on Assets | -13.75% |
| Return on Invested Capital | 49.26% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.15M |
| Employee Count | 71 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.22M |
| Effective Tax Rate | 2.65% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is 0, so DICE Therapeutics's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 45.12 |
| 200-Day Moving Average | 34.83 |
| Relative Strength Index (RSI) | 77.58 |
| Average Volume (20 Days) | 1.75M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -88.22M |
| Net Income | -81.66M |
| EBITDA | -83.01M |
| EBIT | -83.21M |
| Earnings Per Share (EPS) | -2.07 |
Balance Sheet
The company has 461.39M in cash and 13.27M in debt, giving a net cash position of 448.13M.
| Cash & Cash Equivalents | 461.39M |
| Total Debt | 13.27M |
| Net Cash | 448.13M |
| Retained Earnings | -187.59M |
| Total Assets | - |
| Working Capital | - |
Cash Flow
In the last 12 months, operating cash flow was -64.32M and capital expenditures -2.24M, giving a free cash flow of -66.56M.
| Operating Cash Flow | -64.32M |
| Capital Expenditures | -2.24M |
| Free Cash Flow | -66.56M |
| FCF Per Share | -1.69 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DICE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -6.64% |
| FCF Yield | -5.41% |
Analyst Forecast
Currently there are no analyst rating for DICE.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | null |
| Piotroski F-Score | null |